Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of leiomyosarcoma characterized by the presence of an inflammatory infiltrate admixed with malignant spindle cells.
No clinical trials have been registered for inflammatory leiomyosarcoma.
5 publications have been identified in PubMed for inflammatory leiomyosarcoma. Research spans Case Report / Case Series (80%) and Review / Meta-Analysis (20%).
Kalpaka Mohammed MS (2026). [PMID: 41755965](https://pubmed.ncbi.nlm.nih.gov/41755965/). *Cureus*. [Case Report / Case Series]
Nadhirah MS (2025). [PMID: 40567521](https://pubmed.ncbi.nlm.nih.gov/40567521/). *Frontiers in pediatrics*. [Case Report / Case Series]
Folpe AL (2025). [PMID: 40411937](https://pubmed.ncbi.nlm.nih.gov/40411937/). *Seminars in diagnostic pathology*. [Review / Meta-Analysis]
Xu T (2025). [PMID: 40128507](https://pubmed.ncbi.nlm.nih.gov/40128507/). *Discover oncology*. [Case Report / Case Series]
AlAli MM (2024). [PMID: 39070420](https://pubmed.ncbi.nlm.nih.gov/39070420/). *Cureus*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC